Camlin Fine Sciences has informed that the Company has allotted 10,400 equity shares of face value of Re 1 each in accordance with the terms of ESOP 2018 on 15th March, 2024. The said shares have been listed on the Exchanges on 28th March, 2024. Consequent to the said allotment the paid up share capital of the Company has gone up to 167465207equity shares of face value of Re 1 each aggregating to Rs 16,74,65,207.
The above information is a part of company’s filings submitted to BSE.